Stevens Capital Management LP Meridian Bioscience Inc Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 09, 2018
SELL
$13.8 - $16.8 $294,381 - $358,377
-21,332 Closed
0 $0
Q1 2018

May 08, 2018
BUY
$13.8 - $16.2 $294,381 - $345,578
21,332 New
21,332 $303,000
Q4 2017

Feb 13, 2018
SELL
$13.55 - $15.8 $230,336 - $268,584
-16,999 Closed
0 $0
Q3 2017

Nov 01, 2017
BUY
$13.45 - $14.35 $228,636 - $243,935
16,999
16,999 $243,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email